In The News

• 2009-07-01
• Biotech Transfer Week: Fate Therapeutics Licenses Stem-Cell Modulators for Bone Regeneration from UCLA
• 2009-07-01
• Press Release: Fate Therapeutics Granted Exclusive License by The Regents of the University of California to Stem Cell Modulators for Osteo-Regeneration
• 2009-06-29
• San Diego Business Journal: Forum Exchanges Ideas Impacting Drug Approvals
• 2009-06-09
• WIRED Science: Forgotten Drug Helps Stem Cells Repair Bone Marrow
• 2009-06-00
• Drug Discovery News: Catalyst to ‘Industrialize’ Stem Cell Tech
• 2009-06-01
• San Diego Business Journal: Fate Tests Experimental Drug: Treatment Would Help Replenish Blood Systems
• 2009-05-27
• Xconomy: Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants
• 2009-05-27
• Press Release: Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050
• 2009-05-26
• Outsourcing Pharma.com: Fate seeks partners to be iPS Catalyst
• 2009-05-20
• Biotech Transfer Week: Fate Therapeutics Amasses More Academic Stem Cell IP with Children's Hospital Boston Deal
• more...